Tirzepatide has been shown to significantly reduce inflammatory markers including hsCRP and IL-6 in clinical studies
Participants taking semaglutide showed significant reductions in major cardiovascular events, including heart attack and stroke, compared to placebo
The main functions of incretins are shown in Fig
These medications change the way your gut and metabolism communicate
In preclinical research environments, this compound has been studied for its interaction with GLP-1, GIP, and glucagon receptor systems, allowing researchers to evaluate coordinated hormonal signaling pathways within controlled laboratory models
This article is exclusive to STAT+ subscribers Unlock this article plus in-depth analysis, newsletters, premium events, and news alerts